Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner
Executive Summary
Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.
You may also be interested in...
FDA Cancer Chief Pazdur Backed By MD Anderson, Not PhRMA, For Commissioner
FDA Oncology Drug Products Division Director Richard Pazdur, MD, is among the candidates who have been asked to interview for the FDA commissioner position.
FDA Cancer Chief Pazdur Backed By MD Anderson, Not PhRMA, For Commissioner
FDA Oncology Drug Products Division Director Richard Pazdur, MD, is among the candidates who have been asked to interview for the FDA commissioner position.
RU-486 Lower-Dose, Home-Administered Misoprostol Being Evaluated
The Population Council is planning a trial to demonstrate that a 200 mg dose of the abortifacient Mifeprex is effective and that the misoprostol component of the regimen can be safely used at home.